Similar to the RIL-175 tumors, no significant effect in the Acta2 and EMT-associated genes Zeb1 and Zeb2 was seen with proglumide therapy alone in the Dt81Hepa1-6 HCC cells (Supplemental Table S2). This evidence concerns the gene ZEB1 and hepatocellular carcinoma.